Introduction
The secretory pathway in mammalian cells consists of a linear assembly of dynamic compartments. Transport and recycling between these compartments occurs through generation of transport intermediates from the donor compartment and the delivery of such intermediates to the appropriate acceptor compartment. A family of Rab proteins belonging to the Ras superfamily of small GTPases has emerged as essential regulators of all stages of membrane traffic (Pfeffer, 2001; Segev, 2001b; Zerial and McBride, 2001) . Rabs have been proposed to act in diverse aspects of vesicular transport, including vesicle formation, motility, docking, and fusion. However, despite considerable advances, the exact mechanism of Rab function remains unclear.
In the early secretory pathway, two isoforms of Rab1, Rab1a and Rab1b, have been shown to be required for protein transport from the ER to the cis-Golgi (Plutner et al., 1991; Tisdale et al., 1992; Nuoffer et al., 1994; Pind et al., 1994) . A yeast homologue of Rab1, YPT1, is also essential for ER to Golgi transport (Segev et al., 1988) . The cellular function of Rab1 is likely to involve temporally and spatially distinct interactions with its effectors. Two Rab1 effectors have been identified as the tethering factors p115 and GM130 (Allan et al., 2000; Weide et al., 2001 ) (Moyer et al., 2001) . Similarly, in yeast, YPT1 has been shown to genetically interact with the yeast homologue of p115, USO1; (Sapperstein et al., 1996) .
Rabs continuously cycle between a GDP-and a GTP-bound form (Schimmoller et al., 1998) . The GTP-bound conformations is regarded as "active" and can interact with downstream effector proteins (Segev, 2001a; Zerial and McBride, 2001) . Conversion of the GTP-to the GDP-bound form is caused by GTP hydrolysis, facilitated by a GTPase-activating protein.
Following GTP hydrolysis and the corresponding conformational shift, Rabs interact with a GDP dissociation inhibitor (GDI) , that can extract them from the membrane and support their transient existence in the cytosol. The Rab-GDI complex is then specifically recognized by a membrane Rab receptor (the identity of which is unknown) that displaces the GDI and subsequently allows the Rab to bind a new GTP in a reaction mediated by a guanine nucleotide exchange factor.
Since the continuous cycling of Rabs between these states is necessary for their function, mutations that alter nucleotide loading, exchange or hydrolysis can be used to explore Rab's cellular role.
To explore function of Rab1b in vivo, we utilized a "dominant negative" approach proven useful in elucidating the functions of distinct Rabs and their effectors (Zerial and McBride, 2001 ) (Segev, 2001a) . We generated a Q67L mutant with low GTPase activity, a S22N mutant with low affinity for GTP but normal affinity for GDP , and a N121I mutant with low affinity for both GDP and GTP (Pind et al., 1994) . Although some mutants of Rab1b or the equivalent mutants of Rab1a (Q65L, S25N, N124I) have been partially characterized (Tisdale et al., 1992; Nuoffer et al., 1994; Pind et al., 1994) , previous experiments examined limited number of parameters, and utilized different experimental systems. We utilized the same methodology to examine the effects of all the Rab1b mutants on: 1) ER-Golgi traffic, by monitoring the transport of a cargo protein; 2) Golgi and ERGIC structure, by analyzing the localization of resident Golgi and ERGIC proteins; 3) the response of Rab1b effectors by analyzing the behavior of p115 and GM130; 4) the status of the COPII machinery by exploring the behavior of Sec13 and Sec31; and 5) the status of the COPI machinery by exploring the behavior of β-COP.
Our data indicate that expression of the wild type Rab1b and the constitutively active Q67L mutant has limited effect on ER-Golgi trafficking and Golgi structure. In contrast, the inactive S22N mutant causes partial Golgi disruption, while the inactive N121I mutant completely disrupts Golgi structure. The N121I mutant causes BFA-like phenotype and induces the relocation of resident Golgi proteins to the ER and the redistribution of ERGIC53, GM130 and p115 to punctate structures shown in BFA-treated cells to represent ER exit sites and arrested vesicular tubular clusters (VTCs) (Ward et al., 2001) . In addition, N121I causes the dissociation of β-COP from membranes, implicating Rab1b in a pathway leading to COPI recruitment.
Supportive evidence for the role of Rab1b in COPI dynamics was provided by the rescue of the N121I phenotype by expression of ARF1 and GBF1, known mediators of COPI recruitment (Lippincott-Schwartz et al., 1998; Kawamoto et al., 2002) . Similarly, like expression of ARF1 or GBF1, expression of the active Q67L mutant of Rab1b prevented Golgi fragmentation and β-COP dissociation in BFA-treated cells. Together, our data suggest a role for Rab1b in the GBF1/ARF1-mediated pathway for COPI recruitment. Future work will be required to address how Rab1b modulates the COPI recruitment machinery.
Material and Methods
Antibodies. Rabbit polyclonal antibodies against p115 and mouse polyclonal antibodies against GM130 have been described (Barroso et al., 1995; Nelson et al., 1998) . Monoclonal anti-giantin G1/133 (Linstedt and Hauri, 1993) and monoclonal anti-ERGIC53 G1/93 (Schweizer et al., 1988) antibodies were provided by Dr. Hans-Peter Hauri (University of Basel, Basel, Switzerland). Polyclonal antibodies against Mann II (Velasco et al., 1993) were provided by Dr. Marilyn Farquhar (University of California, San Diego, CA). Rabbit polyclonal antiRab1b and anti-myc antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), monoclonal anti-myc antibodies were purchased from Invitrogen (Carlsbad, CA).
Monoclonal anti-VSV-G (P5D4) antibodies (Roman et al., 1988) were provided by Dr. Kathryn Howell (University of Colorado, Denver, CO). Goat anti-rat and anti-mouse antibodies conjugated with Oregon Green or Texas Red-X were purchased from Molecular Probes (Eugene, OR). Antibodies against Sec13 and Sec31 (Tang et al., 2000) were provided by Dr. Bor Luen Tang (National University of Singapore, Republic of Singapore).
Generation of constructs.
GalT-GFP construct was provided by Dr. Brian Storrie (Virginia Tech, Blacksburg, VA) (Storrie et al., 1998) . ARF1 wild type and ARF1Q71L was a gift from Dr. Julie Donaldson (NIH, Bethesda, MD) . Full length Rab1b was cloned into the EcoR I-NotI restriction sites of the pEF6/Myc-His B 6P vector (Invitrogen, Carlsbad, CA). Full length Rab1b was obtained by PCR using as a template a human cDNA library. The primers used for rab1b were 5' cc gga att ccc atg aac ccc gaa tat gac 3' (forward primer); 5' tg ccc gcg gcc gca aca gcc acc gcc agc d 3' (reverse primer) to amplify full length rab1b (sequence data available from Gen Bank under accession number NM030981). Point mutations were introduced with Quick Change Site-Directed Mutagenesis Kit, according to the manufacturer's protocol (Stratagene Corp., La Jolla, CA). All mutated Rab1 sequences were verified by sequencing. GFP-rab1b version were subcloned from their respective rab1-myc constructs into pEGFP-vector. GBF1 was obtained from a partial human GBF1 cDNA (KIAA0248) from the Kazusa DNA Research Institute in Japan. The missing fragment was amplified from a Human lung cDNA library. The PCR product was then subcloned into the KIAA0248 clone using the 6 internal EcoRI site at base 1124 and an engineered external XhoI site. To generate GBFmyc, wtGBF1 was amplified by PCR and subcloned into pcDNA4.0/TO/myc-his (Invitrogen, Carlsbad, CA).
Morphological analysis of VSV-G transport. Analysis was performed as described previously (Alvarez et al., 1999) . Briefly, HeLa cells plated on coverslips were transfected with Rab1 constructs. After 24 hours, cells were infected with VSVtsO45 at 32 o C for 30 min, followed by incubation at 42 o C for 3 h to accumulate VSV-G in the ER. The cells were then shifted to 32 o C for different amounts of time to allow VSV-G transport to the Golgi and the PM. epifluorescence microscope. Optical sections were captured with a CCD high resolution camera equipped with a camera/computer interface. Images were analyzed with a power Mac using IPLab Spectrum software (Scanalytics Inc., Fairfax, VA).
Results

Generation and expression of mutant forms of Rab1b
To generate reagents for our studies, a myc-his tag was added to the C-terminus of wild type and three mutant forms of Rab1b (Q67L, S22N and N121I). Since Rab1b is prenylated on C-terminal cysteine residues , and this modification is important for its membrane association, we also generated wild type and mutant forms tagged at the Nterminus with the green fluorescent protein (GFP). As shown in Figure 1A and B, myc-or GFPtagged proteins of the appropriate molecular weight (~27kDa and ~55kDa, respectively) were detected in lysates from transfected HeLa cells but not in control lysates. Approximately the same amounts of wild type Rab1b and each mutant were detected 24 hours after transfection, as compared to the loading baseline provided by calnexin.
The myc-and GFP-tagged proteins show analogous localization ( Figure 1C and D). The myc-and GFP-tagged wild type and Q67L mutants localize predominantly to morphologically normal Golgi membranes. In contrast, the S22N mutants show more diffuse patterns, most likely representing cytosolic and reticular ER localization. The N121I mutants show diffuse cytosolic staining. Our results with myc-and GFP-tagged Rab1b are identical to previously reported localization of GFP-tagged Rab1a (Moyer et al., 2001b) .
Effects of mutant forms of Rab1b on cargo transport
Previous studies have shown that the S22N and the N121I mutants of Rab1a cause dominant negative effects on secretory traffic (Tisdale et al., 1992; Nuoffer et al., 1994; Pind et al., 1994) . To functionally characterize our Rab1b mutants, we analyzed the transport of a Rab1a showing that VSV-G becomes endo-H resistant in cells transfected with the Q67L mutant (Tisdale et al., 1992) . In cells expressing the S22N mutant, VSV-G is found in peri-nuclear punctate structures and does not transit to the PM, even after 120 minutes at the permissive temperature. This is consistent with biochemical data on Rab1a showing that expression of the S22N mutant in cells prevents endo-H resistance of VSV-G (Tisdale et al., 1992) . In cells expressing the N121I mutant, VSV-G is retained in the ER, consistent with biochemical data on
Rab1a showing Endo-H sensitivity of VSV-G in transfected cells (Tisdale et al., 1992; Pind et al., 1994) .
Effects of mutant forms of Rab1b on Golgi structure
The effects of expressing wild type or mutant Rab1b in vivo have not been previously punctate peri-nuclear structures containing giantin can be seen. An adjacent cell, presumably expressing higher levels of the mutant or for longer, has a completely diffuse giantin pattern.
The distribution of ERGIC53 appears less disturbed, although relocation of the protein from a peri-Golgi region to peripheral structures is observed. Quantitative analysis shows that the vast majority of cells expressing the S22N mutant (88% of transfected cells) or the N121I mutant (85% of transfected cells) present the described phenotypes. The disruption was observed even at moderate and low levels of expression, attesting to the strong dominant effects of these Rab1b mutants in cells.
The effects of the N121I mutant resembled those caused by BFA treatment, and representative images of cells treated with BFA are shown in Figure 3 , BFA panels. BFA treatment causes Golgi disassembly and the relocation of resident Golgi proteins to the ER. BFA also induces relocation of ERGIC53 to punctate structures, shown by others to represent ER exit sites and immature VTCs (Ward et al., 2001) .
We also explored the localization of two Rab1 effectors GM130 and p115 in cells expressing wild type and mutant Rab1b. As shown in Figure 4 , the localization of GM130 and p115 is not influenced by the expression of either the wild type Rab1b or the Q67L mutant. In cells expressing the S22N mutant, GM130 and to a larger extent p115 are redistributed from the Golgi to punctate peripheral structures. In cells expressing the N121I mutant, GM130 and p115 localization is disrupted, and both are found in small punctate structures dispersed throughout the cell. The observed patters are analogous to those induced by BFA treatment (Figure 4 , BFA panels). BFA inhibits the activity of guanine exchange factors (GEFs) for ARFs, and prevents COPI recruitment Helms and Rothman, 1992) . Since expression of the N121I mutant causes BFA-like phenotype, we explored whether Rab1b could be involved in COPI recruitment.
A mutant form of Rab1b perturbs COPI coat assembly
We first examined the effects of Rab1b mutants on the assembly of COPII coats since these have been reported to be unaffected by BFA treatment (Ward et al., 2001) . As shown in Figure   5 , the localization of the Sec13 and the Sec31components of the COPII coat appears normal in cells expressing the wild type or the Q67L mutant. Sec13 and Sec31 are present in punctate structures concentrated in the Golgi region and also in more peripheral sites. In cells expressing the S22N or the N121I mutant, the overall Sec13 and Sec31 pattern still appears normal, but with less peri-Golgi structures. This is mostly likely due to Golgi disruption since distribution of ER exit sites has been shown to be influenced by the Golgi (Ward et al., 2001) . Significantly, even in cells expressing the N121I mutant, both Sec13 and Sec31 are efficiently recruited to ER exit sites.
The results indicate that cells expressing the N121I mutant recruit COPII and ERGIC53 to ER exit sites and immature VTCs, but are unable to sort and deliver resident Golgi proteins into those structures (compare Figures 5 and 3 ). To ensure that this is not due to different N121I expression levels in distinct cells, we compared the localization of Sec31 and ERGIC53 to the localization of a resident Golgi protein (galactosyl transferase -Gal-T) in the same cell. Cells were co-transfected with the N121I mutant and GFP-tagged Gal-T, and the localization of Sec31 or ERGIC53 compared to the localization of GalT-GFP. As shown in Figure 6 , in N121I transfected cells (see inserts), GalT-GFP is detected in a diffuse ER pattern. Gal-T-GFP is not recruited into ER exit sites or immature VTCs, even though Sec31 and ERGIC53 are efficiently sorted and maintained in those structures.
We next explored the distribution of the β-COP component of COPI in cells expressing wild type or mutant Rab1b. As shown in Figure 7 , β-COP panels, in cells expressing the wild type or the Q67L mutant, β-COP distributes to the Golgi and to peripheral sites. The pattern is indistinguishable from that in untransfected cells. In cells expressing the S22N mutant, β-COP pattern is more dispersed and parallels the redistribution observed for ERGIC53. A more dramatic effect is seen in cells expressing the N121I mutant, with the majority of β-COP being in a diffuse cytosolic pattern. The N121I-induced β-COP dissociation is analogous to that seen in BFA-treated cells (Figure 7 , BFA panel).
Since β-COP recruitment requires membrane-associated ARF, and GBF1 has been shown to recruit ARFs to membranes (Kawamoto et al., 2002) , we examined the distribution of GBF1 in cells expressing the wild type Rab1b and the various mutants. As shown in Figure 7 , GBF1 panels, in cells expressing the wild type or the Q67L mutant (transfected cells denoted by asterisks), GBF1 distributes to the Golgi and to peripheral sites. The pattern is indistinquishable from those in neighboring untransfected cells. In cells expressing the S22N mutant, GBF1
localization is altered, with GBF1 relocating to punctate structures concentrated in the Golgi region. A dramatic redistribution of GBF1 is seen in cells expressing the N121I mutant.
Although the distribution of GBF1 appears diffuse, the nuclear membrane is labeled (arrowhead), indicative of ER localization. The N121I-induced GBF1 pattern is analogous to that seen in BFA-treated cells (Figure 7 , BFA panel), in which GBF1 relocates to the ER.
Expression of ARF1 or GBF1 rescues β-COP dissociation induced by a mutant form of
Rab1b
Golgi disruption and β-COP dissociation induced by the N121I mutant are analogous to those induced by BFA. BFA inhibits the activity of a guanine exchange factor for ARFs, and prevents ARF activation Helms and Rothman, 1992) . To determine whether Rab1b-catalyzed events might participate in COPI recruitment, we explored the possibility that the N121I mutant causes its effects through an inhibitory effect on the ARF1-mediated COPI recruitment pathway. If that were the case, than overexpression of ARF1 should rescue the N121I-induced β-COP dissociation. To test this, we co-transfected the N121I mutant with wild type ARF1. Expression of ARF1 has no detectable effect on Golgi structure or β-COP localization (our unpublished results; (Teal et al., 1994) . As shown in Figure 8A , a cell cotransfected with N121I and ARF1 (arrowhead) shows β-COP in a membrane associated Golgilike pattern. In contrast, a cell transfected only with the N121I mutant (asterisk) shows diffuse distribution of β-COP.
Recently, a report identified the Sec7-family member GBF1 as an exchange factor for ARF1 in vivo (Kawamoto et al., 2002) . Since expression of ARF1 rescues the N121I phenotype, we explored whether GBF1 could also reverse the N121I effect. We co-transfected cells with the N121I mutant and wild type GBF1. As shown in Figure 8B , in cells co-transfected with the N121I mutant and GBF1 (arrowheads), β-COP is retained on membranes. β-COP is associated with the Golgi and with punctate peri-Golgi structures. This pattern is analogous to that in cells expressing only GBF1 ( Figure 8C ). The peri-Golgi structures are most likely caused by a GBF1-mediated increase in COPI recruitment to membranes. In cells expressing only the N121I mutant (asterisk), β-COP is diffusely distributed in the cytosol. It appears that both ARF1 and GBF1 can antagonize the effect of the N121I mutant and maintain β-COP association with membranes.
Expression of the active mutant of Rab1b confers BFA resistance to cells
Previous studies have documented that expression of proteins known to be involved in COPI recruitment, such as the active form of ARF1 and GBF1, confers BFA resistance to transfected cells (Teal et al., 1994; Claude et al., 1999; Kawamoto et al., 2002; Zhao et al., 2002) . In agreement, we show that the expression of the active Q71L mutant of ARF1 prevents Golgi redistribution in BFA-treated cells ( Figure 9A ). As shown in that figure, a cell transfected with ARF1-Q71L shows normal Golgi localization of p115 (arrowhead). An adjacent untransfected cell shows the typical BFA-induced p115 pattern (compare to p115 localization in Figure 4 , BFA panel). Similarly, expression of GBF1 confers BFA resistance ( Figure 9A ), in agreement with previous reports (Claude et al., 1999 , Kawamoto et al., 2002 Zhao et al., 2002) . Cells expressing GBF1 show Golgi localization of p115 (arrowheads), while an untransfected cell shows dispersed p115 pattern. Quantitation of the BFA resistance of transfected cells (defined as
Golgi pattern of p115) shows that ~4% of cells transfected with a control plasmid encoding GFP are BFA resistant, while ~41% of cells transfected with the ARF1-Q71L plasmid, and ~39% of cells transfected with the GBF1 plasmid are BFA resistant ( Figure 9B ).
To test whether expression of the active form of Rab1b also confers BFA resistance, we transfected cells with the Q67L mutant and then treated them with BFA. As shown in Figure 9C 
Discussion
Here, we provide a comprehensive analysis of Rab1b function in cells, by examining the effects of mutant forms of Rab1b on; 1) ER-Golgi traffic; 2) Golgi and ERGIC structure; 3) the response of Rab1b effectors; 4) the status of the COPII machinery; and 5) the status of the COPI machinery. In our studies we use Rab1b constructs tagged at the C-terminus with myc or at the N-terminus with GFP. Rabs are post-translationaly prenylated (by addition of a 20-carbon geranylgeranyl to the C-terminal GGCC motif) (Farnsworth et al., 1994) , and prenylation has been shown to be required for membrane association of the yeast homologue of rab1a, YPT1 (Newman et al., 1992) . We did not formally analyze whether our C-terminally myc-tagged constructs are prenylated. However, since the myc-tagged wild type Rab1b efficiently associates with membranes, we assume that the myc tag does not prevent prenylation. It has been shown that Rabs containing the -CCXXX motif are prenylated (Pereira-Leal and Seabra, 2000) , suggesting that addition of C-terminal amino acids might not prevent prenylation. Furthermore, we show that the myc-tagged constructs behave identically to constructs tagged at the Nterminus with GFP and induce the same phenotypes.
Effects of Rab1b mutants
Q67L. The Q67L mutant localizes to peripheral VTCs and to the Golgi, in a pattern indistinguishable from that of a wild type protein. Expression of the Q67L mutant has no detectable effect on any of the tested parameters, in agreement with previously published data (Tisdale et al., 1992) . Although the Q67L mutant is expected to have reduced intrinsic GTPase activity in vitro in cells it is likely to interact with a GAP that would promote GTP hydrolysis to normal levels. The lack of visible enlargement of VTCs or the Golgi in transfected cells differs from the effects observed in the endosomal system where the expression of GTP-restricted Rab5 increases rate of internalization and leads to the formation of enlarged endosomes (Barbieri et al., 1996) (Seachrist et al., 2001 ).
S22N.
The S22N mutant presents a diffuse cellular staining, without a clear compartmental staining. In some cells, a faint nuclear and reticular pattern can be discerned, suggesting that S22N might associate with the ER. The partially cytosolic localization of this mutant is consistent with its preferred GDP status and GDI-mediated extraction from membranes (Alexandrov et al., 1994) . Expression of the S22N mutant leads to inhibition in transport, and the arrest of cargo VSV-G in fragmented peri-nuclear Golgi structures. This is consistent with biochemical data showing that cargo VSV G remains endo-H sensitive in cells expressing the analogous Rab1a mutant (Tisdale et al., 1992) . Cells transfected with S22N show Golgi disruption and relocation of Golgi proteins to peri-nuclear fragments. It is likely that those are analogous to Golgi elements induced in cells by microinjection of the S25N Rab1a mutant, and shown by EM analysis to resemble polarized Golgi mini-stacks formed in the presence of nocodazole (Wilson et al., 1994) . The COPII and COPI machinery are not noticeably perturbed in transfected cells. It is likely that the S22N mutant mediates its effect by competing with the endogenous Rab1b for binding to cellular accessory proteins (possibly GDI or GEF), but does not act as an irreversible inhibitor since its effects can be rescued by overexpression of the wild type protein .
N121I.
The N121I mutant localizes in a diffuse cellular pattern, without associating with a clearly defined compartment. Expression of N121I in cells blocks exit of cargo VSV-G from the ER, and causes the complete disassembly of the Golgi as monitored by the disappearance of Mannosidase II, giantin, GOS28 (not shown) and gal-T from the Golgi region and their redistribution to the ER. This result is completely reproducible when using either myc-tagged or GFP-tagged N121I mutant, and the redistribution of 4 different proteins argues against a proteinspecific phenotype. The collapse of the Golgi is most easily explained by a block in the anterograde pathway and continuing retrograde recycling, in agreement with the established role of Rab1 in the forward traffic (Plutner et al., 1991; Tisdale et al., 1992) . Our findings differ from published data that show arrest in VSV-G transport at the level of VTCs (in cells expressing the N121I mutant (Tisdale et al., 1992) , or in semi-intact cells supplemented with N121I (Pind et al., 1994) , and the relocation of Golgi proteins into peri-nuclear structures (in cells microinjected with the N121I mutant (Wilson et al., 1994) . The rationale for the differences in reported results and our data is currently unclear. However, we provide further experimental support for the disruptive effects of N121I by showing that it causes dissociation of β-COP from membranes. The phenotype we describe is analogous to that observed in cells treated with BFA or expressing the inactive mutant of ARF1 (Dascher and Balch, 1994) . In each case, β-COP is not associated with membranes, there is no sorting of cargo and Golgi proteins into VTCs, and ER-Golgi traffic is inhibited. Recruitment of COPI is required for the maturation of COPII differentiated ER exit sites into transport-competent VTCs, and this process appears inhibited by N121I. The significantly more severe phenotype induced by N121I versus S22N can be explained by the finding that N121I is expected to act as an irreversible inhibitor in vivo since its effects cannot be suppressed by overexpression of wild type Rab1b (Pind et al., 1994) .
Rab1b and its effectors
GM130 has been identified as a Rab1a and Rab1b effector (Moyer et al., 2001a) (Weide et al., 2001) , while p115 has been identified as a Rab1a effector (Allan et al., 2000) . Rab1a shares 92% identity with Rab1b (Touchot et al., 1987) , and we detected p115 interaction with the active Q67L mutant of Rab1b in a yeast di-hybrid system (our unpublished results). Surprisingly, expression of Q67L had limited effect on GM130 and p115 distribution, but expression of S22N, and to an even larger extend, expression of N121I, significantly influenced GM130 and p115 localization. The S22N mutant caused partial relocation of both proteins from the Golgi to peripheral punctate structures, while the N121I mutant caused complete redistribution into a been suggested that the active form of Rab1 is required for the recruitment of p115 to membranes in an in vitro COPII budding assay (Allan et al., 2000) , but our in vivo results indicate that p115 can associate with membranes independent of Rab1 activity. Similarly, the Rab3 effector rabphilin3A also associates with membranes in a manner independent of active Rab3 (Shirataki et al., 1994) . While it appears that p115 recruitment to membranes is mediated by other protein(s), subsequent p115 sorting or function might be regulated by the active Rab1.
Rab1b and COPI recruitment
The ability of the N121I mutant to induce β-COP dissociation from membranes suggests that Rab1b participates in events leading to COPI recruitment. A link between Rabs and COPI is not unexpected since the active form of Rab2 promotes β-COP recruitment to membranes (Tisdale and Jackson, 1998) , and a relationship between Rabs and ARFs has been shown genetically in yeast (Segev, 2001b) . The Rab1b yeast homologue, YPT1, has been shown to interact genetically with GEA2, a guanine nucleotide exchange factor for ARF1/2 (Jones et al., 1999) . Furthermore, there is synthetic lethality between YPT1 and ARF1, suggesting a functional link between these GTPase families. In agreement, we document a functional relationship between Rab1b and ARF1, by showing that: 1) β-COP dissociation induced by N121I can be reversed by overexpression of ARF1; 2) overexpression of GBF1, a mammalian exchange factor for ARF, is also able to reverse β-COP dissociation induced by N121I; and 3) overexpression of the active Q67L mutant reverses β-COP dissociation induced by BFA. The combined data suggest that the Rab and ARF families of GTPases interact in a regulatory cascade mediating COPI recruitment.
A plausible model for Rab1b function is that it might act to recruit or activate GBF1, which in turn activates ARF, which then recruits COPI and allows COPII/COPI exchange on VTCs.
This model fits with the BFA-like phenotype induced by N121I since BFA has been shown to inhibit GEF activity, thus preventing ARF activation and COPI recruitment. The model is also consistent with our findings that Rab1b acts in COPI pathway upstream of ARF1 and GBF1, and that the block induced by N121I preceedes formation of VTCs. Previous work has shown that the ER membrane into ER exit sites occurs through the action of the COPII machinery, and the subsequent maturation to VTCs requires recruitment of the COPI coat. In the absence of active Rab1b, ER exit sites form as shown by the localization of COPII components and the sorting of ERGIC53, GM130 and p115, but such structures do not differentiate into VTCs, as shown by the retention of cargo and Golgi proteins in the ER. That Rab1b might participate in exit from the ER is also strongly suggested by studies in Drosophila expressing the N124I mutant under heat shock promotor where expression of the mutant protein caused extensive ER swelling in addition to the disruption of the Golgi and block in ER to Golgi transport of rhodopsin (Satoh et al., 1997) . Interestingly, expression of N124I also caused the accumulation of clusters of small vesicles (<150nm) close to the ER, perhaps indicating that COPI function is required for their differentiation into VTCs.
Our results significantly extend previous studies examining effects of mutant rab1b on Golgi structure and ER-Golgi transport in vivo and in vitro, and provide support for a novel function of rab1b in COPI coat assembly. Future studies are necessary to elucidate the exact mechanism of rab1b function, to identify all its compartment-specific effectors, and to define all the compartments and traffic steps at which it acts. HeLa cells were transfected with wild type Rab1b, the Q67L mutant, the S22N mutant, or the N121I mutant, and analyzed 24 hrs later by immunofluorescence with anti-myc antibodies to detect transfected cells (denoted by asterisks), and with either anti-GM130, or anti-p115
antibodies (see respective panels). In cells expressing wild type Rab1b or the Q67L mutant, GM130 localizes to the Golgi, while p115 is found in the Golgi and in peripheral punctate structures. In cells expressing the S22N mutant, GM130 and p115 are partially localized to the Golgi, but also show redistribution to peripheral punctate structures. In cells expressing the N121I mutant, both, GM130 and p115 are completely redistributed to peripheral punctate structures. The redistribution of GM130 and p115 is similar to that induced by a 30 min BFA (5 µg/ml) treatment (BFA panels). Bars represent 10µm. HeLa cells were transfected with wild type Rab1b, the Q67L mutant, the S22N mutant, or the N121I mutant (see respective panels), and analyzed 24 hrs later by immunofluorescence with anti-myc antibodies to detect transfected cells (denoted by asterisks) and with either anti-β-COP or anti-GBF1 antibodies. In cells expressing wild type Rab1b or the Q67L mutant, β-COP and GBF1 distribute in normal patterns. In cells expressing the S22N mutant, β-COP and GBF1 present a more punctate peri-Golgi pattern. In cells expressing the N121I mutant, β-COP and GBF1 are not associated with a distinguishable compartment, and appear diffuse. GBF1 is detected in the nuclear membrane (arrowhead) indicating ER localization. The redistribution of β-COP and GBF1 is similar to that induced by a 30 min BFA (5 µg/ml) treatment (BFA panels).
Bars represent 10µm. 
